BUD Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Focus Interparfums Inc IPAR Q1 2026 Earnings EPS Surprises 10 Above Estimates ARDX Q1 2026 Earnings EPS Misses Estimates Amid Quiet Revenue Disclosure Lineage Cell Therapeutics Inc LCTX Q1 2026 Earnings Miss on EPS as ClinicalStage Biotech Continues Development VRTS Q1 2026 Earnings EPS Misses Estimates on Negative Surprise AQMS Q3 2025 Earnings Significant EPS Miss Highlights Ongoing Challenges for PreRevenue Company